tiprankstipranks
Advertisement
Advertisement
Tyra Biosciences Shareholders Reelect Directors and Ratify Auditor
PremiumCompany AnnouncementsTyra Biosciences Shareholders Reelect Directors and Ratify Auditor
1M ago
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
Premium
Ratings
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
2M ago
Tyra Biosciences initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Tyra Biosciences initiated with a Peer Perform at Wolfe Research
2M ago
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
PremiumRatingsDabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
3M ago
Tyra Bioscience Expands Board, Appoints New Independent Director
Premium
Company Announcements
Tyra Bioscience Expands Board, Appoints New Independent Director
3M ago
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
Premium
Company Announcements
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
3M ago
Tyra Bioscience Strengthens Financial Leadership with New Officer
PremiumCompany AnnouncementsTyra Bioscience Strengthens Financial Leadership with New Officer
3M ago
Tyra Biosciences price target raised to $56 from $42 at Piper Sandler
Premium
The Fly
Tyra Biosciences price target raised to $56 from $42 at Piper Sandler
4M ago
Tyra Bioscience Raises $126 Million in Block Share Sale
Premium
Company Announcements
Tyra Bioscience Raises $126 Million in Block Share Sale
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100